MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Taysha Gene Therapies (TSHA) Earnings Date & Reports

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more

A.I. Advisor
published Earnings

TSHA is expected to report earnings to rise 8.44% to -9 cents per share on March 04

Taysha Gene Therapies TSHA Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
The last earnings report on November 04 showed earnings per share of -9 cents, meeting the estimate of -9 cents. With 589.90K shares outstanding, the current market capitalization sits at 1.13B.
View a ticker or compare two or three
TSHA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSHA showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com